Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

bmiMD vs T2D.com

Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, T2D.com a 42. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

bmiMD

#11 · Grade A · Great Deal

Est. first month

$99/mo

Save ~93% vs brand-name
Get this deal Full bmiMD review →
VS

T2D.com

#392 · Grade C · Watch List

Est. first month

From $999/mo (starting dose, compounded)

Save ~26% vs brand-name
Get this deal Full T2D.com review →

The verdict

Better value: bmiMD

bmiMD takes it on Value Score, 89 to 42 an est. $99/mo first month, with no teaser step-up baked in. T2D.com isn't out of it: Shoppers who want diabetic GLP-1 access.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealbmiMDT2D.com
Value Score89 (A)42 (C)
Est. first month$99/moFrom $999/mo (starting dose, compounded)
Save vs brand-name~93%~26%
Semaglutide$99/moFrom $999/mo (starting dose, compounded)
Tirzepatide$139/moFrom $999/mo (starting dose, compounded)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 states1 states

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

95
Lowest Real Price
20
bmiMD: 95. T2D.com: 20.
84
No Teaser-Rate Bait
30
bmiMD: 84. T2D.com: 30.
98
Nationwide Availability
40
bmiMD: 98. T2D.com: 40.
94
Both Molecules
92
bmiMD: 94. T2D.com: 92.
82
Easy Cancellation
58
bmiMD: 82. T2D.com: 58.
70
Reputation
68
bmiMD: 70. T2D.com: 68.

bmiMD

Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.

Why it's a deal

  • $99 flat semaglutide and a low $139 tirzepatide
  • Available in all 50 states
  • Both molecules priced up front

The fine print

  • Not LegitScript-certified — do your own pharmacy diligence
  • Thin public track record; no oral or brand-name option

T2D.com

T2D.com offers a complete service for compounded semaglutide and tirzepatide that includes the prescriber, medication, and home delivery in one integrated solution.

Why it's a deal

  • Built specifically for type 2 diabetic and pre-diabetic patients
  • Integrated service — prescriber, pharmacy, and delivery handled in one flow
  • Offers both compounded semaglutide and compounded tirzepatide
  • Temperature-controlled home delivery via UPS or FedEx
  • Ongoing prescriber monitoring and support included

The fine print

  • No pricing published on the public website — must register to see costs
  • No states list published on the site
  • Newer brand with limited independent reviews
  • Compounded only — no brand-name Ozempic, Wegovy, or Mounjaro
Get the bmiMD deal Get the T2D.com deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores bmiMD is ranked on the bmiMD alternatives board, and the same list for the other side is on alternatives to T2D.com.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.